Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Small Caps RIGL, APWR, SMRT and MAIL Gain on Increased Trading Volumes

|Includes:APWR, PERI, Rigel Pharmaceuticals, Inc. (RIGL), SMRT

Bio-Pharma RIGL leads the pre-market and MAIL releases HiYo to 250 million Yahoo Messenger subscribers.

Stocks did edge higher yesterday, but the indices saw only minor gains in the single digits. Commodities producers, banks and industrial companies saw renewed interest by investors and tech shares and energy continued there steady climb upward. With oil below $60 a barrel today and modest trading across the boards, this is a good time to look at value stocks before they become more expensive this fall.

Rightly priced to me is Rigel Pharmaceuticals (RIGL) http://www.rigel.com/ trading on the Nasdaq in the $13.95 range. RIGL led today's pre-market opening on an upgrade today from Boenning & Scattergood (from neutral to outperform) and on yesterday's aftermarket news that its rheumatoid arthritis drug candidate was shown to reduce patients' symptoms in a mid-stage clinical trial, meeting the study's goal.

RIGL picked up 5.85% ($0.77) this morning on triple its 3-Month average daily trading volume of 418,336 shares to set a new market cap of $577 million.

R788

RIGL said yesterday evening that patients treated with its drug R788, or fostamatinib disodium, had lower scores on two disease scales compared with patients who received a placebo. The company said it plans to find a partner to help develop the oral drug, and then begin late-stage testing in early 2010. RIGL noted that more than 2 million people in the U.S. have rheumatoid arthritis,

Among patients treated with 100 mg of R788 twice per day, RIGL said 66% saw improvement of at least 20% in their symptoms, while 43% had 50% improvement and 28% saw 70% improvement or better.

The reason why I like RIGL is the number of drugs they have in Phase I trials and that R788, which is in Phase 2b clinical trials is proving out and a Phase II clinical trial for the treatment of immune thrombocytopenia purpura, B-cell lymphoma, and T-cell lymphoma; and a preclinical stage for the treatment of lupus is underway.

At $13, 95, RIGL is below its 52-week high of $27.18 (a good buy signal) and is far above its 52-week low of $4.19. RIGL is ahead of both its 50-day and 200-day moving averages and its shares out versus float are at near-parity.

 

A ONE YEAR CHART OF RIGL

Picking up $1.46 (20.39%) on the Nasdaq this morning and currently trading in the $8.50 range is A-Power Energy (APWR) http://www.apowerenergy.com/ which announced today that its unit, the Shenyang Power Group, signed an agreement with the Macau Natural Gas Co to construct a $1.5 billion offshore liquefied natural gas complex.

APWR easily topped its 3-Month average daily volume of 1,719,600 shares in early trading. APWR through its subsidiaries provides onsite distributed power generation systems and micro power grids for industrial companies; and produces wind turbines. APWR designs, constructs, installs, and tests distributed power generation and micro power grids as stand-alone facilities for various customers in the steel, chemical, ethanol, cement, and food industries.

At $8.50, APWR is far below its 52-week high of $31.80 and well above its 52-week low of $3.00. It's below its 50-day moving average and above its 200-day moving average. APWR has trailing twelve month revenues of $263 million.

Before I introduce Stein Mart inc., (SMRT) http://www.steinmart.com/ here's a chart from their primary sector of business.

DJ US Apparel Retailers Index

S&P 600 SmallCap member SMRT jumped up 7.31% ($0.57) in early trading today and is currently in the $8.38 range on the Nasdaq. The jump was caused by yesterday's news that the retailer's same store results for the five weeks in June, had dropped 8% and its 22 week, year-to-date decrease was 6.5%. Considering the number of bankruptcies and massive cut-backs in retail, buyers saw these figures as acceptable the morning after and started buying early. SMRT easily passed its 3-Month average daily trading volume of 400,878 shares in early trading.

During June, SMRT's best performing categories continued to be dresses and ladies' casual sportswear. The most difficult businesses were ladies' career sportswear and gifts. Stores in the West and in the Ohio Valley led the Company's sales performance, while stores in the Southeast and in the mid-Atlantic experienced the weakest trends. There were 273 SMRT stores in operation at July 4, 2009 as compared to 284 at the same time last year.

At $8.38, SMRT is below its 52-week high of $9.20 (set on the first day of this month) and is far above its 52-week low of $0.99 set on 12-19-08. On $1.29 billion in trailing twelve month revenues, SMRT is above both its 50-day and 200-day moving averages.

And finally a follow-up on a stock I highlighted on July 1st, IncrediMail Inc., (MAIL) http://www.incredimail-corp.com/ currently trading in the $6.20 range (picking up 6% this morning) on the Nasdaq that announced on Tuesday it has released a new version of its instant messaging add-on software, HiYo. This new version supports Yahoo! Messenger, which currently boasts over 250 million registered users.

HiYo is a 100% free add-on that includes emoticons, animations, and sounds, without advertisements. Previous versions of HiYo only supported Microsoft Live Messenger (NYSEMKT:MSN), with its over 300 million users worldwide. MAIL's award winning e-mail client product, IncrediMail Premium, is sold in over 100 countries in 10 different languages.

MAIL's jump in trading volume was significant this morning If you look at the chart below, you can see the trendline of the stocks value.

 

Sign up for our amazing free newsletter at smallcapnetwork.com

Stocks: RIGL, APWR, SMRT, PERI